VX-702 10mg 10mg | Purity Not Available
Adooq Bioscience
VX-702 is an orally bioavailable inhibitor of p38 MAP kinase that inhibits platelet agonist induced p38 activation (IC50= 4 to 20 nM).
More Information Supplier PageVX-702 is an orally bioavailable inhibitor of p38 MAP kinase that inhibits platelet agonist induced p38 activation (IC50= 4 to 20 nM).
More Information Supplier PageVX-680 is a potent and selective small-molecule inhibitor of the Aurora kinases.
More Information Supplier PageVX-680 is a potent and selective small-molecule inhibitor of the Aurora kinases.
More Information Supplier PageVX-680 is a potent and selective small-molecule inhibitor of the Aurora kinases.
More Information Supplier PageVX-680 is a potent and selective small-molecule inhibitor of the Aurora kinases.
More Information Supplier PageVX-680 is a potent and selective small-molecule inhibitor of the Aurora kinases.
More Information Supplier PageVX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
More Information Supplier PageVX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
More Information Supplier PageVX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
More Information Supplier PageVincristine is a mitotic inhibitor, and is used in cancer chemotherapy.
More Information Supplier Page